下一代定序资讯学市场－全球产业规模、份额、趋势、竞争、机会和预测，按产品与服务、应用、最终用户、地区和竞争细分，2020-2030 年

2024 年全球次世代定序 (NGS) 资讯学市场价值 54.8 亿美元，预计到 2030 年将达到 187.4 亿美元，复合年增长率为 22.74%。由于癌症发病率的上升和 NGS 临床应用的不断扩大，市场正在经历大幅成长。 2020 年，全球癌症观察站记录了超过 1,900 万例新发癌症病例，其中最常见的是乳癌、肺癌、大肠癌、摄护腺癌和胃癌。 DNA 定序样本数量的增加、定序成本的下降、政府支持的基因组计划以及 NGS 相对于传统微阵列技术的日益普及，都促进了市场扩张。随着定序变得更加经济实惠且成为疾病诊断和治疗不可或缺的一部分，对能够管理、分析和解释大规模基因组资料的强大资讯学平台的需求持续增长。

关键市场驱动因素

精准医疗和基因组诊断的应用日益普及

主要市场趋势

人工智慧和机器学习在NGS资讯学中的整合

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球下一代定序（NGS）资讯学市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品和服务（储存和计算工具、商业数据分析、数据解释和报告工具、下一代定序 (NGS) 资讯学服务、实验室资讯管理系统 (LIMS)）
  • 按应用（药物发现、基因筛检、疾病诊断等）
  • 按最终用户（医院和诊断中心、製药和生物技术公司、学术和研究机构）
  • 按地区（北美、欧洲、亚太、南美、中东和非洲）
  • 按公司分类（2024）
• 市场地图
  • 按产品和服务
  • 按应用
  • 按最终用户
  • 按地区

第六章：北美次世代定序（NGS）资讯学市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲次世代定序（NGS）资讯学市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区次世代定序（NGS）资讯学市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲

第九章：南美下一代定序（NGS）资讯学市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲下一代定序 (NGS) 资讯学市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 阿联酋
  • 沙乌地阿拉伯
  • 南非

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品/服务的威胁

第 14 章：全球下一代定序 (NGS) 资讯学市场：SWOT 分析

第 15 章：竞争格局

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• PerkinElmer, Inc.
• SOPHiA GENETICS SA
• Precigen, Inc.
• QIAGEN NV
• Illumina, Inc.
• Agilent Technologies, Inc.
• Eagle Genomics Limited
• BGI Genomics Co., Ltd.

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Next Generation Sequencing (NGS) Informatics Market was valued at USD 5.48 billion in 2024 and is projected to reach USD 18.74 billion by 2030, growing at a CAGR of 22.74%. The market is witnessing substantial growth due to the increasing incidence of cancer and expanding clinical applications of NGS. In 2020, the Global Cancer Observatory recorded over 19 million new cancer cases, with breast, lung, colorectal, prostate, and stomach cancers being the most common. Contributing to market expansion are the rising number of DNA sequencing samples, declining sequencing costs, government-backed genomic initiatives, and growing adoption of NGS over traditional microarray technologies. As sequencing becomes more affordable and integral to disease diagnosis and treatment, the demand for robust informatics platforms capable of managing, analyzing, and interpreting large-scale genomic data continues to grow.

Key Market Drivers

Rising Adoption of Precision Medicine and Genomic-Based Diagnostics

The widespread integration of precision medicine and genomic diagnostics into clinical workflows is a key driver of the NGS informatics market. By enabling the analysis of entire genetic profiles, NGS facilitates identification of disease-causing mutations and supports individualized treatment strategies. Government-led initiatives such as the NIH's "All of Us Research Program" reflect this trend, collecting genetic data from over one million participants-over 600,000 of whom had enrolled by 2023. This surge in data fuels the demand for informatics platforms that can store, process, and interpret high-throughput sequencing information. Additionally, broader insurance coverage for genomic testing in countries like the United States is encouraging greater adoption of NGS technologies in hospitals and clinical labs. According to CMS, spending on NGS-based tests has significantly increased, underlining the growing clinical importance of these tools. As a result, demand for scalable NGS informatics systems that can automate variant analysis and support clinical decisions using AI and ML is accelerating across healthcare systems.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning in NGS Informatics

The integration of AI and ML into NGS informatics is revolutionizing genomic data analysis by enabling rapid, accurate, and efficient interpretation of complex datasets. These technologies are embedded into pipelines for variant calling, annotation, and clinical reporting, helping to identify structural rearrangements and polygenic risk scores. Tools like DeepVariant and AlphaFold have improved the interpretation of genomic data in oncology and rare disease diagnostics. Government backing, such as the U.S. National Artificial Intelligence Initiative and the EU's Horizon Europe program, underscores global efforts to integrate AI in biomedical research. AI models also enhance the utility of genomic data when integrated with electronic health records, enabling personalized, evidence-based treatment recommendations. As these models become increasingly sophisticated and validated, they are expected to become central to commercial NGS informatics solutions, supporting the broader implementation of precision medicine.

Key Market Players

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• PerkinElmer, Inc.
• SOPHiA GENETICS SA
• Precigen, Inc.
• QIAGEN N.V.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Eagle Genomics Limited
• BGI Genomics Co., Ltd.

Report Scope:

In this report, the Global Next Generation Sequencing (NGS) Informatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing (NGS) Informatics Market, By Product & Services:

• Storage and Computing Tools
• Commercial Data Analysis
• Data Interpretation and Reporting Tools
• Next Generation Sequencing (NGS) Informatics Services
• Laboratory Information Management Systems (LIMS)

Next Generation Sequencing (NGS) Informatics Market, By Application:

• Drug Discovery
• Genetic Screening
• Disease Diagnosis
• Others

Next Generation Sequencing (NGS) Informatics Market, By End User:

• Hospitals and Diagnostic Centers
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutions

Next Generation Sequencing (NGS) Informatics Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Next Generation Sequencing (NGS) Informatics Market.

Available Customizations:

Global Next Generation Sequencing (NGS) Informatics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing (NGS) Informatics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Informatics Services, Laboratory Information Management Systems (LIMS))
  • 5.2.2. By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others)
  • 5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Products & Services
  • 5.3.2. By Application
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Next Generation Sequencing (NGS) Informatics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Products & Services
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Next Generation Sequencing (NGS) Informatics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Products & Services
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Next Generation Sequencing (NGS) Informatics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Products & Services
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Next Generation Sequencing (NGS) Informatics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Products & Services
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing (NGS) Informatics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Products & Services
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Products & Services
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
      • 7.3.1.2.4. By Country
  • 7.3.2. France Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Products & Services
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Products & Services
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Products & Services
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Products & Services
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Next Generation Sequencing (NGS) Informatics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Products & Services
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Products & Services
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Japan Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Products & Services
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. India Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Products & Services
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Products & Services
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Products & Services
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Next Generation Sequencing (NGS) Informatics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Products & Services
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Next Generation Sequencing (NGS) Informatics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Products & Services
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Next Generation Sequencing (NGS) Informatics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Products & Services
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Next Generation Sequencing (NGS) Informatics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Products & Services
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Next Generation Sequencing (NGS) Informatics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Products & Services
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. UAE Next Generation Sequencing (NGS) Informatics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Products & Services
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Products & Services
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. South Africa Next Generation Sequencing (NGS) Informatics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Products & Services
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Global Next Generation Sequencing (NGS) Informatics Market: SWOT Analysis

15. Competitive Landscape

• 15.1. Abbott Laboratories
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. F. Hoffmann-La Roche Ltd.
• 15.3. PerkinElmer, Inc.
• 15.4. SOPHiA GENETICS SA
• 15.5. Precigen, Inc.
• 15.6. QIAGEN N.V.
• 15.7. Illumina, Inc.
• 15.8. Agilent Technologies, Inc.
• 15.9. Eagle Genomics Limited
• 15.10. BGI Genomics Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer